LB Pharmaceuticals Inc Common Stock
Support and Resistance Levels
Past performance
News About LBRX
All events for LBRX
All deals for LBRX
Financial Ratios
Financial Statements
LBRX vs Sector & Peers
About LB Pharmaceuticals Inc Common Stock
This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride. Website lbpharma.us
Headquarters New York, NY, US